|Bid||70.35 x 800|
|Ask||70.46 x 900|
|Day's Range||69.69 - 72.52|
|52 Week Range||51.88 - 112.25|
|Beta (3Y Monthly)||0.60|
|PE Ratio (TTM)||16.62|
|Earnings Date||Feb 28, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||72.33|
Magellan Health (MGLN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
closed up Wednesday 11.43% to $72.45 on a Reuters report that said the healthcare management services company was facing pressure from hedge fund Starboard Value to sell itself. Starboard Value is the company's third-largest institutional investor, according to Yahoo Finance, with an 8.64% stake representing a value of about $120.5 million. Magellan, which is advised by Goldman Sachs Group, is in the early stages of considering acquisition interest, though there is no certainty that a deal will materialize, according to the report.
(Adds Ophir Energy, Alitalia, Bristol-Myers Squibb, Cemex, Tilray, Magellan Health, Verus Petroleum, Owens & Minor; Updates Bank Audi, Sainsbury) Feb 20 (Reuters) - The following bids, mergers, acquisitions ...
(Reuters) - U.S. healthcare plan and pharmacy benefits manager Magellan Health Inc will explore selling itself after coming under pressure to do so from activist hedge fund Starboard Value LP, people familiar ...
Magellan Rx Management, the pharmacy benefit management (PBM) division of Magellan Health, Inc. (MGLN) released its ninth annual Medical Pharmacy Trend ReportTM. The benchmark report is the industry’s premier detailed resource that offers data for analyzing medical benefit drug claims as well as current medical benefit drug management strategies. Commercial per-member-per-month (PMPM) medical drug spend increased 18 percent to $29.97, above the 14 percent average annual trend over the last five years.
Magellan Health, Inc. today announced that it will report its earnings for the fourth quarter and full year ended on December 31, 2018 at approximately 6:30 a.m. Eastern on Thursday, February 28, 2019.
Magellan Health Inc NASDAQ/NGS:MGLNView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is extremely low for MGLN with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting MGLN. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding MGLN totaled $906 million. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Today we are going to look at Magellan Health, Inc. (NASDAQ:MGLN) to see whether it might be an attractive investment prospect. Specifically, we're going to calculate its Return On Capital Read More...
Plus, other significant moves in holdings of Tribune Media, Donnelly Financial, Rent-A-Center, Telaria, Atlantic Power, and five others.
Looking for stocks with high upside potential? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what statistics have to say about hedge funds’ stock picking abilities to illustrate. The Standard and Poor’s 500 Index returned approximately 5.7% in the 12 months ending October 26 […]
Activist hedge fund Starboard Value has accrued a 9.8 percent stake in small health insurer and pharmacy-benefits manager Magellan Health.
NEW YORK, Dec. 06, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
The insurer and pharmacy-benefits manager plans to name a successor to Sam Srivastava, CEO of its health-insurance division. The move follows repeated cuts to the company’s profit forecasts.
The Scottsdale, Ariz.-based company, which provides health management services, said Wednesday it fired Sam Srivastava, chief executive of its health-care unit, according to a securities filing. A Magellan spokeswoman declined to comment.
Health care management company Magellan Health Inc. said Wednesday that Chief Executive Sam Srivastava will be terminated without cause on Dec. 28. The company made the disclosure in a regulatory filing without providing any further details. It said Srivastava will be entitled to 12 months' base salary and the continuation of medical and other benefits under COBRA. Chairman Barry Smith will assume the duties of CEO alongside his other duties. Shares were not active premarket, but have fallen 44.7% in 2018, while the S&P 500 has gained 0.3%.
Magellan Health Inc (NASDAQ:MGLN) is a small-cap stock with a market capitalization of US$1.3b. While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, they Read More...